These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1433893)
41. [Basic and clinical studies of cefminox in obstetrics and gynecology]. Kubota K Jpn J Antibiot; 1985 May; 38(5):1319-30. PubMed ID: 3930803 [TBL] [Abstract][Full Text] [Related]
42. [Fundamental and clinical studies on cefminox]. Okada T; Furukawa S Jpn J Antibiot; 1985 Mar; 38(3):743-50. PubMed ID: 3875739 [TBL] [Abstract][Full Text] [Related]
43. [Study on cefotaxime in respiratory surgery: transfer to lung tissue and kinetics in serum]. Morita J; Hamaguchi N; Yoshizawa K; Niki S; Kondo K Jpn J Antibiot; 1989 Nov; 42(11):2406-11. PubMed ID: 2621782 [TBL] [Abstract][Full Text] [Related]
44. [A clinical trial of astromicin, a new aminoglycoside antibiotic, in thoracotomized patients and astromicin concentrations in the lung tissue]. Imaizumi M; Niimi T; Uchida Y; Asaoka M; Ozika T; Amano Y; Uchida T; Hirai K; Kazita M; Abe T Jpn J Antibiot; 1988 Nov; 41(11):1635-49. PubMed ID: 3210298 [TBL] [Abstract][Full Text] [Related]
45. [Investigation on clinical efficacy and passage into ascites of cefminox in diffuse peritonitis associated with infantile acute appendicitis]. Itagaki K; Ishihara M; Okabe I; Morita K Jpn J Antibiot; 1990 Oct; 43(10):1667-73. PubMed ID: 2086810 [TBL] [Abstract][Full Text] [Related]
46. [Basic and clinical studies on cefminox in obstetrics and gynecology]. Kisaka Y; Hiraoka H; Matsuoka T; Tanaka S; Kishida H; Aihara M; Urabe T; Fujiwara A Jpn J Antibiot; 1985 May; 38(5):1287-300. PubMed ID: 3930799 [TBL] [Abstract][Full Text] [Related]
47. [Pharmacokinetics and antimicrobial effect of cefminox in serum and ascitic fluid for experimental purulent peritonitis in mice]. Azuma Y; Tanimura H; Aoki Y; Isii T; Goi H Nihon Geka Hokan; 1989 Sep; 58(5):445-51. PubMed ID: 2701930 [TBL] [Abstract][Full Text] [Related]
48. [Transfer of cefminox to tissues in the field of obstetrics and gynecology]. Shimizu T; Sengoku K Jpn J Antibiot; 1985 May; 38(5):1198-202. PubMed ID: 3930786 [TBL] [Abstract][Full Text] [Related]
49. [Pharmacokinetic study on aspoxicillin transfer into pulmonary and tracheal tissues]. Nakai K; Tokushima T; Hirota Y; Nagamatsu M; Takeda K; Mizobe M; Takai C Jpn J Antibiot; 1993 May; 46(5):367-73. PubMed ID: 8326676 [TBL] [Abstract][Full Text] [Related]
50. [Antibacterial activities of piperacillin in several fresh clinical isolates]. Matsuzaki K; Koyama H; Omika K; Hasegawa M; Sato Y; Kobayashi I; Kaku M Jpn J Antibiot; 2000 Aug; 53(8):573-81. PubMed ID: 11070819 [TBL] [Abstract][Full Text] [Related]
51. [Fundamental study of piperacillin sodium in term and premature neonates]. Watanabe T; Nakamura I; Nonoda T; Koyasu H; Hojyo Y; Kozaki T; Hata T Jpn J Antibiot; 1987 Jul; 40(7):1311-6. PubMed ID: 3682184 [TBL] [Abstract][Full Text] [Related]
52. [Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)]. Tanimura H; Saito T; Sekiya T; Kobayashi N; Hikasa Y Jpn J Antibiot; 1981 Oct; 34(10):1401-9. PubMed ID: 6460883 [TBL] [Abstract][Full Text] [Related]
53. Transfer of piperacillin to various uterine tissues. Piperacillin study group for application in the field of obstetrics and gynecology. Takase Z Biol Res Pregnancy Perinatol; 1984; 5(2):48-56. PubMed ID: 6743731 [TBL] [Abstract][Full Text] [Related]
54. [Basic study on cefminox in the field of obstetrics and gynecology]. Doko F Jpn J Antibiot; 1985 May; 38(5):1301-3. PubMed ID: 3930800 [TBL] [Abstract][Full Text] [Related]
55. [Safety and pharmacology of aspoxicillin in healthy volunteers]. Matsumoto K; Shishido H; Uzuka Y; Nagatake T; Yamamoto M; Sakuma Y; Maezawa I; Yamaguchi T Jpn J Antibiot; 1985 Oct; 38(10):2699-715. PubMed ID: 4078992 [TBL] [Abstract][Full Text] [Related]
56. [Clinical study of cefmenoxime in thoracic surgery. Transfer of cefmenoxime to lung tissue and pleural fluid and prophylaxis of postoperative infections]. Imaizumi M; Niimi T; Kajita M; Uchida T; Kamiya I; Takahashi T; Uchida Y; Asaoka M; Abe T Jpn J Antibiot; 1987 Sep; 40(9):1628-38. PubMed ID: 3480362 [TBL] [Abstract][Full Text] [Related]
57. [Antibacterial activity of cefminox in human urine]. Goi H; Watanabe T; Hara T; Ishii T; Kazuno Y; Inouye S Jpn J Antibiot; 1988 Jan; 41(1):25-36. PubMed ID: 3367512 [TBL] [Abstract][Full Text] [Related]
58. Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections. Jhee SS; Kern JW; Burm JP; Yellin AE; Gill MA Pharmacotherapy; 1995; 15(4):472-8. PubMed ID: 7479200 [TBL] [Abstract][Full Text] [Related]
59. [Antibacterial activities of piperacillin for several resistant strains from respiratory infections--in reference to MRSA, PRSP, BLNAR and P. aeruginosa]. Matsuzaki K; Koyama H; Omika K; Hasegawa M; Sato Y; Kobayashi I; Watanabe A Jpn J Antibiot; 2000 Aug; 53(8):566-72. PubMed ID: 11070818 [TBL] [Abstract][Full Text] [Related]
60. [Tissue concentrations of piperacillin in humans]. Bergogne-Berezin E Presse Med; 1986 Dec; 15(46):2324-7. PubMed ID: 2949277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]